We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 1VBK market cap is 807.57M. The company's latest EPS is EUR 0.3136 and P/E is 22.03.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 884.89M | 1.04B | 1.82B | 1.99B | 1.67B |
| Operating Income | 91.72M | 138.97M | 448.16M | 205.45M | 67.66M |
| Net Income | 63.38M | 93.2M | 315.63M | 132.02M | 19.96M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 529.2M | 678.62M | 1.13B | 1.3B | 1.38B |
| Total Liabilities | 138.38M | 168.75M | 310.16M | 385.36M | 449.54M |
| Total Equity | 390.82M | 509.87M | 818.46M | 911.83M | 928.22M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 71.68M | 117.18M | 325.03M | 26.09M | 116.78M |
| Investing | -87.68M | -46.56M | -113.62M | -266.43M | -144.9M |
| Financing | 2.24M | -18.76M | -18.48M | 112.21M | -19.53M |
| Market Cap | 807.57M |
| Price to Earnings Ratio | 22.03 |
| Price to Sales Ratio | 0.26 |
| Price to Cash Ratio | 3.57 |
| Price to Book Ratio | 0.47 |
| Dividend Yield | 1.58% |
| Shares Outstanding | 63.64M |
| Average Volume (1 week) | 207 |
| Average Volume (1 Month) | 185 |
| 52 Week Change | -47.39% |
| 52 Week High | 24.12 |
| 52 Week Low | 9.60 |
| Spread (Intraday) | 0.27 (2.15%) |
| Company Name | Verbio SE |
| Address |
thura mark 18 zoerbig 06780 |
| Website | https://www.verbio.de |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
